Le Lézard
Classified in: Health, Business
Subject: CON

Medline Awarded Laboratory Distribution Agreement with Intalere


NORTHFIELD, Ill., Jan. 21, 2019 /PRNewswire/ -- Medline, a global manufacturer and distributor of medical and laboratory products with patient-centered solutions, services and expertise across the continuum of care, today announced it has been awarded a group purchasing agreement for laboratory distribution services with Intalere, effective January 1, 2019 for two years. 

Medline Logo (PRNewsfoto/Medline)

Intalere members already have access to competitive pricing through Medline as their primary medical distributor through a 4-year agreement renewed in February 2018.  This new laboratory contract complements what is in place by extending this negotiated pricing to Intalere members that also select Medline to be their primary laboratory distributor. 

With more than 40 distribution centers strategically located across the country, Medline offers Intalere members with hospitals, independent laboratories, and physician office laboratories access to a broad laboratory product portfolio from hundreds of manufacturers.

"This new contract comes at the request of members looking for a new laboratory distribution option," says Dan Johns, vice president, national accounts, Medline.  "Members can now receive laboratory supplies on the same Medline trucks already delivering their medical supplies.  We look forward to collaborating with Intalere members to balance their needs for clinical quality with savings and efficiency."    

Learn more about Medline laboratory distribution capabilities at https://www.medline.com/pages/supply-chain/lab-distribution-solutions/.

About Medline
Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company strategically supports nearly a third of the largest healthcare systems in the United States as an exclusive prime vendor and has experienced year-over-year distribution growth for more than a decade. Customers across the continuum of care have access to 550,000+ medical devices and support services through more than 1,600 dedicated sales representatives. Learn more about Medline at www.medline.com.

About Intalere
Intalere's mission focuses on elevating the operational health of America's healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers' individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare's nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit www.intalere.com to learn more.

 

SOURCE Medline


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: